This is the authors' abstract. We don't add key points for this paper.
Cyclosporine A (CsA) is highly variable pharmacokinetically and has a narrow therapeutic window; the serum level of patients treated with CsA must be monitored carefully. We investigated the trough and second-hour serum levels of CsA, the calculated area under the curve (AUC), and their association of those factors with chronic allograft dysfunction in pediatric patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Savas et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: